Uri Lopatin

Bio

Uri Lopatin, MD was a co-founder and the Chief Medical Officer of Assembly Pharmaceuticals (2012) and CMO/VP R&D for Assembly Biosciences (f\k\a Ventrus Bioscience), which reverse merged with Assembly Pharmaceuticals in 2014. He has helped Assembly raise over $300M to move their first 2 generations of novel therapeutics into global phase 1 and phase 2 clinical studies. Uri has held clinical and translational science roles at Schering Plough, Roche, and Gilead Sciences. He previously received his medical training at UMDNJ-NJMS, UW, NYU and the NIH.